Illumina, Inc. (BMV:ILMN)

Market Cap	265.19B
Revenue (ttm)	88.40B
Net Income (ttm)	-24.73B
Shares Out	n/a
EPS (ttm)	-155.53
PE Ratio	n/a
Forward PE	n/a
Dividend	56.00 (3.35%)
Ex-Dividend Date	n/a

Volume	1,535
Average Volume	176
Open	1,681.00
Previous Close	1,699.94
Day's Range	1,672.00 - 1,684.07
52-Week Range	1,672.00 - 3,094.82
Beta	n/a
RSI	2.40
Earnings Date	Apr 25, 2025

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Laboratory Analytical Instruments
• Founded: 1998
• Employees: 9,030
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ILMN

Financial Performance

In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.

Financial numbers in USD